Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Blood|July 1, 1981
Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphomaR I Fisher, S M Hubbard, V T DeVita, et al.Annals of Internal Medicine|May 1, 1980
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's diseaseR I Fisher, V T DeVita, F Bostick, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosineP M Politi, F Xie, W Dahut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Twenty years of MOPP therapy for Hodgkin's diseaseD L Longo, R C Young, M Wesley, et al.Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.Annals of Internal Medicine|May 1, 1984
Prolonged initial remission in patients with nodular mixed lymphomaD L Longo, R C Young, S M Hubbard, et al.Journal of Dairy Science|May 1, 2012
Breed differences over time and heritability estimates for production and reproduction traits of dairy goats in the United StatesT B García-Peniche, H H Montaldo, M Valencia-Posadas, et al.Annals of Internal Medicine|March 1, 1986
Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapyM J Browne, S M Hubbard, D L Longo, et al.Cancer Research|October 1, 1979
Phase I trial of N-(phosphonacetyl)-L-aspartateC Erlichman, J M Strong, P H Wiernik, et al.The New England Journal of Medicine|March 19, 1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's diseaseD W Blayney, D L Longo, R C Young, et al.Pageof 6